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Development of a new High 
Resolution Melting (HRM) assay for 
identification and differentiation 
of Mycobacterium tuberculosis 
complex samples
Patricia Landolt  1, Roger stephan2 & simone Scherrer1
The rapid identification and differentiation of members of the Mycobacterium tuberculosis complex 
(MTBC) is essential to assess the potential zoonotic risk. Different available molecular methods are 
time consuming since they depend on cultivation of mycobacteria. High Resolution Melting (HRM) is a 
low cost, rapid and easy to perform single-tube method not limited to cultured samples. In this study, 
a HRM assay specifically targeting gyrB was developed to simultaneously identify and differentiate 
Mycobacterium (M.) tuberculosis, M. microti and M. bovis/M. caprae. To evaluate the performance of 
this assay, 38 MTBC isolates and 25 directly extracted clinical specimens were analysed. HRM results 
of all 38 (100%) examined isolates correlated with the results obtained with the commercially available 
GenoType MTBC test (Hain Lifescience). From the 25 clinical specimens tested, species identification by 
HRM showed concordant results with the previously used identification methods in 23 samples (92%). 
The assay demonstrated a good analytical sensitivity, specificity and reproducibility and can be used 
directly on clinical specimens.
Mycobacterium tuberculosis complex (MTBC) consists of the closely related species Mycobacterium (M.) tubercu-
losis, M. bovis, M. bovis Bacillus Calmette and Guérin (BCG), M. caprae, M. africanum, M. microti, M. pinnipedii, 
M. canettii and three further species (M. orygis, the dassie bacillus, M. mungi)1. M. tuberculosis and M. africanum 
are often described as host-specific to humans. According to the recent WHO report from 2017, tuberculosis 
is still the leading cause of human death from a single infectious agent with 6.3 million new cases and an esti-
mated 1.7 million deaths in 20162. Additionally, several cases of M. tuberculosis infections in animals have been 
reported3–5. Bovine tuberculosis (bTB) is an important zoonosis most commonly caused by M. bovis and less 
frequently by M. caprae1. New cases of bTB in 2013 in Switzerland6, resulting in the implementation of a national 
bTB surveillance program, highlighted the importance of routine species-level identification. This program 
consists of a systematic microbiological testing of suspicious lymph nodes found linked to meat inspection in 
slaughterhouses. Fast and reliable identification and differentiation between the species within this MTB com-
plex is important to assess the potential zoonotic risk and is therefore a fundamental procedure for public health 
surveillance and food safety.
Identification of MTBC is based on different PCR based methods targeting 16S rRNA or IS61107,8. In con-
trast, differentiation of Mycobacterium species within the MTBC is more laborious. Diverse molecular methods 
such as the GenoType MTBC test (Hain Lifescience, Nehren, Germany) or restriction fragment length polymor-
phism9,10 are used although having limitations in the reliance on bacterial cultures to produce a valid amount of 
bacterial DNA. Mycobacteria especially M. microti requires several months to obtain significant growth under-
lining a delayed time span to get valid results of MTBC species-level identification. Spoligotyping uses poly-
morphism on the direct repeat locus for differentiation and typing of MTBC11. A result is obtained in one or 
1Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 270, 8057, Zurich, 
Switzerland. 2Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 272, 
8057, Zurich, Switzerland. Correspondence and requests for materials should be addressed to P.L. (email: patricia.
landolt@uzh.ch)
Received: 2 July 2018
Accepted: 21 December 2018
Published: xx xx xxxx
opeN
www.nature.com/scientificreports/
2Scientific RepoRts |          (2019) 9:1850  | https://doi.org/10.1038/s41598-018-38243-6
two days comprising several working steps such as PCR, membrane preparation, hybridisation, washing steps 
and detection by chemiluminescence. On the other hand, newer alternatives to conventional spoligotyping such 
as Luminex technology or Spoligotyping by MALDI-TOF MS requires advanced and expensive equipment12. 
Numerous single-tube multiplex RT-PCR assays have been previously proposed for MTBC species discrimina-
tion, mainly targeting several region of differences (RD)13–17. The complexity of a multiplex RT-PCR reaction can 
be a problem for intricate veterinary samples often dealing with animal tissues.
High resolution melting (HRM) assay is reported as a rapid and low cost assay to detect single-nucleotide 
polymorphism (SNP)18. The assay characterizes amplified PCR products according to their dissociation behav-
iour without requiring additional instrumentation. A fluorescently labelled dye binding to double stranded DNA 
is combined with amplicons resulting from the PCR reaction. When increasing the temperature, the double 
stranded DNA dissociates into single strands leading to a decrease in fluorescence intensity. The melting temper-
ature depends on GC content, length and nucleotide sequence. It is an easy to perform and single-tube method 
leading to a result within approximately two hours. Moreover, HRM is not limited to cultured material but is able 
to detect DNA in clinical specimens directly extracted from tissue samples. Various HRM assays are already used 
successfully to identify and differentiate many bacteria species such as Mycoplasma synoviae19, Chlamydiaceae 
sp.20, Staphylococcus aureus21, Brucella sp.22 and Leptospira sp.23. Among Mycobacteria sp. HRM is a tool often 
reported to analyse drug resistance in M. tuberculosis24–26. Furthermore, the method is used to differentiate 
non-tuberculous mycobacteria (NTM) and to distinguish them from MTBC27–29. Wright et al. designed a HRM 
assay to detect the Region of Deletion 9 (RD9) with the aim of differentiating M. tuberculosis from other members 
of MTBC in fine-needle aspiration biopsies30. However, the drawback of this study lies in its poor sensitivity of 
only 51.9%. Other studies combined RD-targeted multiplex RT-PCR assays with HRM14,17. In this study, a novel 
HRM method based on SNPs located in gyrB was developed to simultaneously identify and differentiate members 
of MTBC to its species-level.
Results
HRM Analysis with Cultured Samples. All cultured samples tested were amplified and resulted in a cor-
responding melting curve. The HRM species-specific melting temperatures Tm (Table 1, Supplementary Table S1) 
and the corresponding melting curves (Fig. 1a) of the sample-subset used for determination of the intra- and 
inter-assay reproducibility are shown. Since the Tm ranges are very close to each other, it is difficult to clearly 
distinguish between members of MTBC. On the other hand, the difference plot (Fig. 1c) as well as the normal-
ized plot (Fig. 1b) allowed a clear species differentiation into the three groups of M. tuberculosis/M. africanum, 
M. microti and M. bovis/M. caprae. The intra-assay coefficiences of variation (CVs) and the inter-assay CVs 
showed values ranging between 0.01–0.02% and 0.02–0.03%, respectively (Table 1, Supplementary Table S1). 
Species identification results of all 38 (100%) tested cultured samples correlated with the GenoType MTBC test 
(Hain Lifescience) results.
HRM Analysis with Clinical Specimens. 25 clinical specimens were tested in the HRM assay and resulted 
in three main groups consistent with the expected MTBC species. The obtained normalized and difference plots 
of the tested subset of clinical specimens showed a clear discrimination (Fig. 2b,c). The intra-assay CVs (Table 2, 
Supplementary Table S2) were between 0.01–0.02% for M. tuberculosis and M. caprae, 0.01% for M. bovis and 
0.05% for M. microti. The inter-assay CVs (Table 2, Supplementary Table S2) were higher than in the cultured 
samples with values between 0.12–0.15%. From those 25 clinical specimens 23 (92%) showed concordant iden-
tification results. Two samples revealed lower Tm values at approximately 84 °C, compared to the other sample 
results. The corresponding culture of one of those two clinical specimens (sample 17–2287) showed a correct 
species identification by HRM. The second clinical specimen (sample 17-1063) is not successfully cultured yet 
and further investigations are still ongoing.
Analytical Specificity. In the exclusivity run the tested 41 NTMs and Nocardia paucivorans, Escherichia 
coli and Streptococcus suis either showed no melting curves or melting curves with completely different Tm values 
compared to those obtained from samples of the MTBC. Therefore, the assay showed an analytical specificity of 
100%.
Run 1 Run 2 Run 3 Inter-Assay
CV% Tm values CV% Tm values CV% Tm values CV% Tm values
M. tuberculosis H37Rv 86.93 86.98 86.95
M. bovis BCG Pasteur ATCC 35734 86.60 86.58 86.58
M. microti ATCC 19422 86.75 86.72 86.73
M. tuberculosis (n = 3) 0.02 86.99 ± 0.04 0.01 86.98 ± 0.03 0.02 87.00 ± 0.03 0.02 86.99 ± 0.04
M. caprae (n = 6) 0.02 86.57 ± 0.04 0.02 86.58 ± 0.05 0.01 86.62 ± 0.04 0.03 86.59 ± 0.06
M. bovis (n = 6) 0.02 86.58 ± 0.05 0.02 86.60 ± 0.05 0.02 86.64 ± 0.04 0.03 86.60 ± 0.07
M. microti (n = 7) 0.02 86.74 ± 0.07 0.02 86.73 ± 0.05 0.01 86.75 ± 0.05 0.03 86.74 ± 0.07
Table 1. Melting temperatures (mean and standard deviation) of the intra- and inter-assay of a randomly 
chosen subset of cultured samples for different MTBC species with its corresponding coefficients of variation 
(CV) in % are listed.
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Limit of Detection. The limit of detection (LOD) for the lowest dilution of which the acceptance criteria 
were fulfilled was 10 genome equivalents (GE) for M. tuberculosis, M. bovis/M. caprae and M. microti (Table 3).
Efficiency. The efficiencies of the RT-PCR were 87% for M. microti, 94% for M. bovis and 85% for H37Rv 
(Supplementary Fig. S1).
Discussion
This study reports the development of a HRM assay to identify and distinguish the main members of the MTBC 
complex of clinical specimens and cultured samples in approximately two hours. M. microti, M. tuberculosis/M. 
africanum and M. bovis/M. caprae can be clearly and reliably distinguished from each other by unique difference 
plots. The Tm alone is not sufficient to discriminate the main species because of partially overlapping Tm values 
(Tables 1 and 2). However, after appropriate transformation of the melting curves into normalized and difference 
plots by applying algorithms of the Rotor-Gene Q Software 2.3.1 (Qiagen Hilden, Germany), the members of the 
MTBC can be clearly distinguished into three groups (Figs 1c and 2c). Using this strategy, the species-specific 
melting profiles showed an unambiguous picture.
Figure 1. Representative high resolution melting graphs corresponding to one high resolution melting analysis 
of a subset of cultured samples (n = 22). Curves of tested samples previously identified as M. tuberculosis are 
shown in yellow, M. microti in blue, M. bovis/M. bovis BCG in red and M. caprae in green. (a) Melting curves; 
(b) Normalized plot; (c) Difference plot.
www.nature.com/scientificreports/
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To date, MTBC species identification is often based on methods requiring cultured samples10 or based on 
time-consuming procedures11. Halse et al. reported the development of a multiplex RT-PCR method for clinical 
specimens, however, this assay is more expensive due to the need of five different probes16. Furthermore, the 
complexity of such a multiplex reaction can be challenging when analysing tissue samples comprising various 
substances containing large amounts of co-extracted host DNA and ingredients, which can lead to inhibition of 
the PCR reaction31. Other studies evaluated mainly cultured isolates13–15,17. The main advantage of our developed 
HRM assay compared to previous studies is the implementation of a relatively cheap and straightforward single-
plex method for directly extracted clinical specimens.
The current HRM assay identified MTBC positive cultured samples in complete agreement with results of the 
GenoType MTBC test (Hain Lifescience). The clinical specimens showed a concordance of 92%. The remaining 
8% (n = 2) showed unspecific melting curves not allowing to assign the samples to MTBC using the developed 
method. Both samples derived from alpaca tissues, either from spleen or from a mix of different tissues including 
lymph node, lung, heart, liver and cervical vertebra. All 23 clinical samples lead to an unambiguous and correct 
result derived from lymph nodes, lung or liver tissues (Supplementary Table S3). It is likely that the content of 
Figure 2. Representative high resolution melting graphs corresponding to one high resolution melting analysis 
of a subset of clinical specimens (n = 19). Curves of tested samples previously identified as M. tuberculosis are 
shown in yellow, M. microti in blue, M. bovis/M. bovis BCG in red and M. caprae in green. (a) Melting curves; 
(b) Normalized plot; (c) Difference plot.
www.nature.com/scientificreports/
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these particular alpaca tissues interfered with the melting procedure. Further investigations to clarify this finding 
are continuing.
The intra- and inter-assay CVs showed very low values demonstrating a very good reproducibility of 
the method. The analytical specificity displayed a perfect value of 100% indicating a MTBC specific assay. 
Furthermore, the assay demonstrated a good PCR efficiency of more than 85% and a good sensitivity with a LOD 
of 10 GE.
One limitation of the assay is its inability to distinguish between M. bovis, M. bovis BCG and M. caprae with 
this particular primer set. Moreover, M. africanum cannot be separated from M. tuberculosis. In order to design 
a HRM assay having a high resolution detecting SNPs, the PCR amplicon should optimally not exceed 150 bp 
since longer amplicons would have a negative impact on the resolution of the assay. SNPs distantly located within 
a gene, as in the case of gyrB, are impossible to analyse by HRM using just one primer pair. Our primary goal 
was to clearly distinguish M. microti from other members of the MTBC complex since its proper identification in 
directly extracted clinical samples are advantageous considering its long cultivation time. Therefore, our devel-
oped HRM assay was restricted to the detection of 2 out of 5 possible SNPs within the gyrB gene10 resulting in a 
clear and rapid identification and differentiation of the three main MTBC species most relevant to veterinarians. 
In order to overcome the described limitation, there is the possibility to extend the HRM assay with a second 
primer pair, resulting in a two-reaction HRM paradigm, targeting a region to further discriminate M. bovis from 
M. caprae and M. africanum from M. tuberculosis. In addition, another drawback of the developed assay seems to 
lie in the failure of detection of samples deriving from certain alpacas (two out of four tested alpacas), especially 
samples containing spleen or bone.
Run 1 Run 2 Run 3 Inter-Assay
CV% Tm values CV% Tm values CV% Tm values CV% Tm values
M. tuberculosis H37Rv 86.80 86.93 86.75
M. bovis BCG Pasteur ATCC 35734 86.38 86.55 86.37
M. microti ATCC 19422 86.52 86.70 86.48
M. tuberculosis (n = 2) 0.01 86.73 ± 0.01 0.02 86.91 ± 0.03 0.02 86.70 ± 0.03 0.13 86.80 ± 0.13
M. caprae (n = 5) 0.01 86.27 ± 0.17 0.02 86.45 ± 0.15 0.02 86.34 ± 0.12 0.12 86.35 ± 0.25
M. bovis (n = 6) 0.01 86.41 ± 0.06 0.01 86.59 ± 0.04 0.01 86.36 ± 0.04 0.15 86.48 ± 0.16
M. microti (n = 7) 0.03 86.59 ± 0.04 0.02 86.73 ± 0.05 0.02 86.48 ± 0.05 0.14 86.60 ± 0.17
Table 2. Melting temperatures (mean and standard deviation) of the intra- and inter-assay of a randomly 
chosen subset of clinical specimens for different MTBC species with its corresponding coefficients of variation 
(CV) in % are listed.
MTBC Member Genome equivalents Ct SD
M. tuberculosis H37Rv
1'000'000 16.42 0.10
100'000 19.89 0.02
10'000 23.76 0.07
1000 27.48 0.08
100 31.21 0.32
10 35.04 0.27
1 — —
M. bovis BCG pasteur 
ATCC 35734
1'000'000 15.13 0.20
100'000 18.61 0.16
10'000 22.05 0.16
1000 25.75 0.17
100 29.38 0.20
10 33.15 0.50
1 35.51 0.12
M. microti ATCC 19422
1'000'000 15.73 0.06
100'000 19.03 0.05
10'000 22.98 0.07
1000 26.28 0.13
100 30.18 0.17
10 33.92 0.14
1 37.82 0.73
Table 3. Limit of detection of the real-time PCR step within the HRM assay. Determination of Ct values and its 
standard deviation (SD) of 3 replicates for a dilution series ranging from 1 to 1'000'000 genome equivalents using 
the three reference strains M. tuberculosis H37Rv, M. bovis Pasteur ATCC 35734 and M. microti ATCC 19422.
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Conclusions
The developed HRM assay enables the simultaneous identification and differentiation of MTBC between the 
three clinically most relevant groups namely M. tuberculosis/M. africanum, M. microti and M. bovis/M. caprae 
from tissue samples as well as from cultured material. Therefore, the use of this powerful assay may save several 
months of cultivation time to differentiate between species of MTBC. It is an easy to perform, cheap, sensitive 
and specific assay leading to a result in less than two hours. Since tuberculosis is one of the top 10 causes of death 
worldwide, it is expected that a cost-effective and easy to set-up assay could be implemented in laboratories with 
moderate resources as a high-throughput screening and confirmatory tool for MTBC infections. This would sig-
nificantly contribute to develop efficient public health and veterinary surveillance strategies worldwide.
Methods
Ethics statement. This study was carried out in accordance with the recommendations of Swiss federal 
regulations (TSV 916.401 and VSFK 817.190). Analysis of animal specimens was carried out within an official 
context of monitoring bovine tuberculosis and NTM infections, meaning that no animals were killed for the pur-
poses of this research project and ethical approval was not necessary.
Reference strains and samples. 62 MTBC positive samples originating from 40 different animals and 
tissues (Table 4, Supplementary Table S3) were used for assay development. One additional isolate of a wild boar 
was kindly provided by Lucía de Juan Ferré and Beatriz Romero Martinez from the European Union Reference 
Laboratory for Bovine Tuberculosis in Madrid. Finally, a total of 63 samples comprising 38 isolates and 25 clin-
ical specimens were tested. Reference strains M. microti ATCC 19422, M. bovis BCG Pasteur ATCC 35734 and 
M. tuberculosis H37Rv were included as positive controls in each run. To determine the specificity of the 
optimized HRM assay a set of 41 different non-tuberculous mycobacteria (NTM) was additionally tested 
(Supplementary Table S4). Moreover, Nocardia paucivorans, Escherichia coli and Streptococcus suis were included 
in this exclusivity panel in order to test for any non-specific signals.
Culture and DNA extraction. Sample preparation, culture and DNA extraction were proceeded as 
described previously6. Briefly, genomic DNA was extracted harvesting mycobacteria from 1.5 ml of MGIT sub-
cultures by centrifugation for 10 min at 13,000 × g. The sediment was suspended in 180 µl ATL buffer (Qiagen), 
transferred onto a bead beating matrix in a 2 ml microtube (Omni International, Kennesaw, USA), heat inac-
tivated and subjected to mechanical cell lysis using a TissueLyser II (Qiagen) and enzymatic digestion with 
Proteinase K (Qiagen). Automated DNA preparation was performed on the QIAcube instrument using the 
QIAamp cador Pathogen Mini Kit protocol (Qiagen). DNA concentration was measured using a NanoDrop 
2000c Spectrophotometer (Thermo Fisher Scientific, Reinach, Switzerland) and stored at −20 °C until use. DNA 
obtained from pure mycobacterial cultures were identified as MTBC using artus M. tuberculosis RG PCR Kit 
(Qiagen). Species identification of cultured samples was performed by GenoType MTBC test (Hain Lifescience). 
Clinical specimens were tested by Spoligotyping32 and multi-locus variable number tandem repeat analysis 
using an internationally established 24-loci panel33. Standard biosecurity procedures have been carried out for 
handling of samples. Cultures involving MTBC or NTM isolates were performed at the Biosafety Level 3 facil-
ity until heat deactivation. Sample preparation and DNA extraction were carried out under Biosafety Level 2 
containment.
Species Host No. of isolates
cultured material (n = 38)
M. tuberculosis elephant 3
M. caprae cow 7
M. bovis cow 15
M. microti cat 7
M. microti alpaca 3
M. microti llama 2
M. microti wild boar (Spain) 1
clinical specimens (n = 25)
M. tuberculosis elephant 2
M. caprae cow 5
M. bovis cow 7
M. microti cat 5
M. microti alpaca 4
M. microti llama 2
Total 63
Table 4. MTBC positive samples used for the development of the HRM method. 38 isolates obtained from 
cultured material, whereas 25 samples were clinical specimens directly extracted from tissue samples. 62 
samples derived from Switzerland whereas one isolate originated from Spain.
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HRM development and optimisation. A primer pair was designed specifically targeting a conserved 
region for MTBC on the gyrB gene. The forward HRM_gyrB_for (5′-CGGCTCGAAGTCGAGATCAAG-3′) and 
reverse HRM_gyrB_rev (5′-TTCGAAAACAGCGGGGTCG-3′) primers flank a 144 base pair (bp) amplicon. In 
contrast, other closely and distantly related NTM have a greater variability in the primer region as well as in the 
whole 144 base pair amplicon (Fig. 3).
The HRM assay was performed on the Rotor-Gene Q system (Qiagen) with the Type-it HRM PCR Kit 
(Qiagen). The reaction was performed in a total volume of 15 µl. 1 µl of sample DNA was added to a reaction 
mixture containing 7.5 µl 2X Type-it HRM Mastermix containing EvaGreen DNA-binding dye (Qiagen), 0.5 µM 
final concentration of each primer (Microsynth AG, Balgach, Switzerland) and ultrapure water. The PCR ther-
mocycling conditions were as follows: initial denaturation at 95 °C for 5 min, 40 cycles with denaturation at 95 °C 
for 10 s and annealing/extension at 55 °C for 30 s followed by a second cycling step at 95 °C for 10 s and 40 °C for 
2 min followed by a HRM ramping from 80 °C to 93 °C. Fluorescence data were acquired at 0.1 °C increments 
every 2 s to generate specific melting curves. For each experiment, the three reference strains M. microti ATCC 
19422, M. bovis BCG Pasteur ATCC 35734 and M. tuberculosis H37Rv were included as melting curve standards 
and positive controls. To exclude contaminations in the reaction mixture, ultrapure water was added as a negative 
control in each experiment.
Data analysis was performed using Rotor-Gene Q Software 2.3.1 (Qiagen). Normalized and difference plots 
were generated. To normalize the results, the pre-melt (initial fluorescence) and post-melt (final fluorescence) 
signals of all samples were set to uniform relative values from 100% to 0%. In order to generate difference plots, 
normalized fluorescence data of sample curves were subtracted from a reference curve of M. bovis BCG Pasteur 
ATCC 35734 to visually accentuate differences in a greater resolution. The threshold value for peak calling was set 
at 0.5 dF/dT. In order to alleviate false negative results due to inhibition, clinical specimens were tested in dupli-
cate undiluted and as a 1:5 dilution. The cultured samples were tested at concentrations between 100 pg and 10 ng.
To examine the intra- and inter-assay CV of the Tm, representing the repeatability of the developed HRM 
method, a randomly chosen subset of 22 cultured and 19 clinical specimens were tested in triplicates in three 
independent runs at three different days.
Analytical Specificity. In order to proof the analytical specificity of the primers an exclusivity panel includ-
ing NTMs, Nocardia paucivorans, Escherichia coli and Streptococcus suis were tested.
Efficiency and limit of detection. The efficiency and the analytical sensitivity of the RT-PCR were evalu-
ated by triplicate testing of a 10-fold serial dilution series of each of the three reference strains. With an estimated 
genome size of 4.4 Mb, a DNA quantity of 4.8 fg was calculated for one GE of MTBC. The limit of detection was 
determined as lowest dilution with amplification of all triplicates with a standard deviation of ≤0.5.
Data Availability
Data generated during the study is presented in an analysed format in this manuscript. Raw datasets generated 
from the intra- and inter-assays are included in the Supplementary Information file. Additional raw data are 
available from the corresponding author on reasonable request.
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